Ivabradine in Cardiovascular Disease Management Revisited: a Review
Sign Up to like & getrecommendations! Published in 2021 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-020-07124-4
Abstract: Ivabradine is a unique agent that is distinct from beta-blockers and calcium channel blockers as it reduces heart rate without affecting myocardial contractility or vascular tone. Ivabradine is a use-dependent inhibitor targeting the sinoatrial node.… read more here.
Keywords: ivabradine cardiovascular; heart; heart failure; cardiovascular disease ... See more keywords